10 Hot Biotech Stocks Under $5 to Buy
On June 4, 2026, CNBC reported that global biopharma M&A is on track for its strongest year since the pre-pandemic peak seven years ago.
| No. | Hedge Fund | Shares | Value | Activity | % Port |
|---|---|---|---|---|---|
| 1. | Decheng Capital Min Cui | 4,447,308 | $14,231,386 | 1.94% | |
| 2. | ADAR1 Capital Management Daniel Schneeberger | 3,758,569 | $12,027,421 | +1% | 0.55% |
| 3. | Woodline Partners Michael Rockefeller And Karl Kroeker | 3,500,901 | $11,202,883 | 0.03% | |
| 4. | RA Capital Management Peter Kolchinsky | 3,096,336 | $9,908,275 | 0.09% | |
| 5. | StemPoint Capital Michelle Ross | 2,016,607 | $6,453,142 | 1.11% |
| Insider | Price | Amount | Total Value | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $2.93 | 14,584 | $42,736.95 | 62,586 | 2026-06-05 | Filing | |
| $2.94 | 30,975 | $91,069.60 | 762,025 | 2026-06-05 | Filing | |
| $3.16 | 200,000 | $632,760.00 | 793,000 | 2026-06-04 | Filing | |
| $2.95 | 65,000 | $191,750.00 | 0 | 2026-05-28 | Filing | |
| $2.98 | 30,208 | $90,019.84 | 62,586 | 2026-05-28 | Filing |
| No. | Name | Shares | Value | % Port |
|---|---|---|---|---|
| 1. | 6,494,571 | $20,685,209 | 0.01% | |
| 2. | 4,100,000 | $13,120,000 | 0.59% | |
| 3. | 3,631,659 | $11,621,309 | 0.02% | |
| 4. | 1,822,812 | $5,832,998 | 0% | |
| 5. | 381,175 | $1,220,357 | 0% |